Published 23 October 2008, doi:10.1136/bmj.a2186
Cite this as: BMJ 2008;337:a2186

Views & Reviews

Personal View

(Not) warts and all

Phil Hammond, general practitioner, writer, and broadcaster

hamm82@msn.com

The first 150 words of the full text of this article appear below.

"You’d be mad not to protect your daughter against genital warts if you can afford to." So advised Peter Greenhouse, a sexual health consultant in Bristol, when I asked him which human papillomavirus vaccine I should choose for my daughter. The NHS vaccination programme may have opted for the bivalent vaccine (Cervarix) to concentrate resources on preventing cervical cancer, but every doctor I’ve spoken to has chosen the quadrivalent vaccine (Gardasil) for their own daughters (and the odd son, though of course this is off licence).

Genital warts are common (100 000 new cases in England each year), and the condition is on the rise, particularly among young people: in women 60% of cases occur in the 16-24 years age group. They don’t kill you, but they can kill your sex life, and in some people they can be recurrent and extensive. The health minister Dawn Primarolo claims that warts . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Government fully considered HPV vaccine
David M Salisbury
BMJ 2008 337: a2552. [Extract] [Full Text]

"Annoyance" of genital warts
Colm O’Mahony
BMJ 2008 337: a2553. [Extract] [Full Text]

All data on both vaccines must be considered
Pim Kon
BMJ 2008 337: a2554. [Extract] [Full Text]

Related external webpages:

Listen to podcast interview with Phil Hammond.

This article has been cited by other articles:

  • Morris, S. R (2009). HPV vaccine strategies: the cost of HPV and the choice of vaccine. Sex. Transm. Infect. 85: 315-316 [Full text]  
  • Salisbury, D. M (2008). Government fully considered HPV vaccine. BMJ 337: a2552-a2552 [Full text]  
  • O'Mahony, C. (2008). "Annoyance" of genital warts. BMJ 337: a2553-a2553 [Full text]  
  • Kon, P. (2008). All data on both vaccines must be considered. BMJ 337: a2554-a2554 [Full text]  

Rapid Responses:

Read all Rapid Responses

Not for the boys either!
Tim J Harrison
bmj.com, 24 Oct 2008 [Full text]
Over optimistic view
Patrick Silvestre
bmj.com, 26 Oct 2008 [Full text]
Important to take into consideration all scientific data on both vaccines
Pim Kon
bmj.com, 26 Oct 2008 [Full text]
Controlling Information Controls Budgets
Graham M Kyle
bmj.com, 28 Oct 2008 [Full text]
HPV and the larynx
Peter D Bull
bmj.com, 28 Oct 2008 [Full text]
Gardasil: warts and everything else ...
Mark Struthers
bmj.com, 28 Oct 2008 [Full text]
Cervical cancer vaccine in developing countries: hype or hope?
Joseph L. Mathew, et al.
bmj.com, 1 Nov 2008 [Full text]
Ethical issues as well
Paquita C. de Zulueta
bmj.com, 9 Dec 2008 [Full text]
warts and other nonsense
Richard J. stockley
bmj.com, 6 Nov 2008 [Full text]
Full consideration of HPV vaccine
David M Salisbury
bmj.com, 6 Nov 2008 [Full text]
Who’s mad?
Veerle Piessens, et al.
bmj.com, 4 Nov 2008 [Full text]
Phil Hammond, you need more adjectives
Hanmant Ganpati Varudkar
bmj.com, 4 Nov 2008 [Full text]
Genital warts - annoying? Really?
Colm O'Mahony
bmj.com, 6 Nov 2008 [Full text]
Cervical cancer and melanoma interventions contrasted
Stephen F Hayes
bmj.com, 7 Nov 2008 [Full text]
Vaccination for genital warts to prevent cervical cancer: principles first, please, before details
Felix ID Konotey-Ahulu
bmj.com, 12 Nov 2008 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ